Mckesson is a medical distribution company located in Texas, United States, which is part of the Healthcare sector, and is traded under the ticker MCK on the NYSE exchange.
Mckesson stock last closed at $564.52, up 1.58% from the previous day, and has increased 40.79% in one year. It has overperformed other stocks in the Medical Distribution industry by 0.14 percentage points. Mckesson stock is currently +51.23% from its 52-week low of $373.28, and -0.26% from its 52-week high of $566.01.
As of May 17, 2024, there are 129.99M MCK shares outstanding. The market value of MCK is $73.38B. In the past 24 hours, 574,559 MCK shares were traded.
You need an online brokerage account to access the NYSE market and buy MCK stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your stock purchase by opening an account with eToro now.
Open eToro AccountNow that you've selected the right brokerage, you need to fill out some personal info so you are able to invest in MCK today.
Now that you have finished signing up on the best stock app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your new brokerage account.
After you have figured out the best place to buy Mckesson stock, it's critical to research their stock before you buy, so you actually understand the risk as well as the opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can view all of the due diligence checks on MCK's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge MCK's fair value.
Using relative valuations ratios:
You can access additional valuation analysis on MCK's stock here.
Out of 12 Wall Street analysts who give forecasts on MCK, the consensus analyst rating on Mckesson is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Kevin Caliendo, a top 18% analyst from UBS maintains MCK with a strong buy rating and raises their MCK price target from $620.00 to $630.00, on May 8, 2024.
Eric Coldwell, a top 21% analyst from Baird maintains MCK with a buy rating and raises their MCK price target from $603.00 to $671.00, on May 8, 2024.
Daniel Grosslight, a top 23% analyst from Citigroup maintains MCK with a strong buy rating and raises their MCK price target from $575.00 to $620.00, on Apr 30, 2024.
Citigroup's Daniel Grosslight raised their price target on Mckesson (NYSE: MCK) by 7.8% from $575 to $620 on 2024/04/30. The analyst maintained their Strong Buy rating on the stock.
Grosslight's update arrived in a pre-print review of names in their Healthcare Technology (Medical Distribution) sector coverage area, published ahead of Mckesson's Q4 and FY 2024 earnings report on 2024/05/07.
Although the analyst expressed optimism about distributors in general, Grosslight cautioned that Q1 2025 would be challenging from a comp standpoint.
The analyst detailed that GLP-1 growth will decelerate significantly, and distributors will not reap much profit from commercial COVID vaccinations.
Yahoo Finance reports that the current consensus EPS estimate for the company's Q4 is $6.35 which, if achieved, would represent an 11.7% decline from Q4 2023's $7.19.
Erin Wright, a top 5% analyst from Morgan Stanley maintains MCK with a strong buy rating and raises their MCK price target from $522.00 to $548.00, on Apr 15, 2024.
David Toung, a top 18% analyst from Argus Research maintains MCK with a strong buy rating and raises their MCK price target from $510.00 to $570.00, on Apr 10, 2024.
You can dive deeper into what analysts are saying on the Mckesson stock forecast page.
Last year, MCK earnings were $3.00B. During the past 5 year, MCK's earnings have gone up by 165.77% per year. This was faster than the Medical Distribution industry average of 93.16%.
Last year, MCK revenue was $308.95B. In the past five year, MCK's revenue has grown by 7.59% per year. This was slower than the Medical Distribution industry average of 8.29%.
You can analyze MCK's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at MCK have sold more shares than they have bought.
Susan R. Salka, Director of MCK, was the latest MCK insider to sell. They sold $2,232.15 worth of MCK shares on May 10, 2024.
Research more about who owns MCK shares here.
Mckesson pays a dividend of 0.43%, compared to the Medical Distribution industry's average dividend yield of 1.85%. If you owned $1,000 of MCK stock, you would have been paid $4.25 last year.
Mckesson dividend payments have consistently grown over the past decade and have remained stable.
Find more data about Mckesson dividend yield and history here.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two primary options:
Click the Open button and your broker will place the order.
If you need additional info about buying stocks on eToro, click the how to video below:
Now that you own some MCK stock, you'll want to keep up with your new company.
Make a watchlist to track the latest developments regarding your MCK stock.
To reiterate, here are the 6 steps you need to take to buy Mckesson stock right now:
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Mckesson, get started below.